{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T02:32:33Z","timestamp":1783823553536,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00405-018-5178-y","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T23:57:10Z","timestamp":1541030230000},"page":"93-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Molecular interactions in juvenile nasopharyngeal angiofibroma: preliminary signature and relevant review"],"prefix":"10.1007","volume":"276","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2289-9104","authenticated-orcid":false,"given":"Anupam","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riddhi","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pandey","family":"Amita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. C.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"key":"5178_CR1","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215116000268","author":"A Mishra","year":"2016","unstructured":"Mishra A, Mishra SC (2016) Changing trends in the incidence of juvenile nasopharyngeal angiofibroma: seven decades of experience at King George\u2019s Medical University, Lucknow, India. J Laryngol Otol. https:\/\/doi.org\/10.1017\/S0022215116000268","journal-title":"J Laryngol Otol"},{"issue":"9","key":"5178_CR2","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1017\/S0022215117001372","volume":"131","author":"A Mishra","year":"2017","unstructured":"Mishra A, Mishra SC, Pandey A (2017) Variations in molecular expressions of juvenile nasopharyngeal angiofibroma. J Laryngol Otol 131(9):752\u2013759","journal-title":"J Laryngol Otol"},{"issue":"5","key":"5178_CR3","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1017\/S0022215116000773","volume":"130","author":"A Mishra","year":"2016","unstructured":"Mishra A, Mishra SC, Verma V, Singh HP, Kumar S, Tripathi AM, Patel B, Singh V (2016) In defence of transpalatal, transpalatal-circumaxillary (transpterygopalatine) and transpalatal-circumaxillary-sublabial approaches to lateral extensions of juvenile nasopharyngeal angiofibroma. J Laryngol Otol 130(5):462\u2013473. https:\/\/doi.org\/10.1017\/S0022215116000773","journal-title":"J Laryngol Otol"},{"key":"5178_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/lary.26250","author":"P Pandey","year":"2016","unstructured":"Pandey P, Mishra A, Tripathi AM, Verma V, Trivedi R, Singh HP, Kumar S, Patel B, Singh V, Pandey S, Pandey A, Mishra SC (2016) Current molecular profile of juvenile nasopharyngeal angiofibroma: first comprehensive study from India. Laryngoscope. https:\/\/doi.org\/10.1002\/lary.26250","journal-title":"Laryngoscope"},{"key":"5178_CR5","first-page":"317","volume":"37","author":"A Mishra","year":"2016","unstructured":"Mishra A, Sachadeva M, Jain A, Mishra Shukla N, Pandey A (2016) Human Papilloma virus in Juvenile Nasopharyngeal Angiofibroma: possible recent trend. Am J Otolaryngol Head Neck Med Surg 37:317\u2013322","journal-title":"Am J Otolaryngol Head Neck Med Surg"},{"key":"5178_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-018-5110-5","author":"A Mishra","year":"2018","unstructured":"Mishra A, Mishra SC, Tripathi AM, Verma V, Pandey A (2018) Clinical Correlation of Molecular (VEGF, FGF, PDGF, c-Myc, c-Kit, Ras, p53) Expression in Juvenile Nasopharyngeal Angiofibroma. Eur Arch Otorhinolaryngol. https:\/\/doi.org\/10.1007\/s00405-018-5110-5","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"5178_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00405-006-0202-z","volume":"264","author":"R Schuon","year":"2007","unstructured":"Schuon R, Brieger J, Heinrich UR, Roth Y, Szyfter W, Mann WJ (2007) Immunohistochemical analysis of growth mechanisms in juvenile angiofibroma. Eur Arch Otorhinolaryngol 264:389\u2013394","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"5178_CR8","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.2741\/4077","volume":"17","author":"L Xiao","year":"2012","unstructured":"Xiao L, Du Y, Shen Y, He Y, Zhao H, Li Z (2012) TGF-beta 1 induced fibroblast proliferation is mediated by the FGF-2\/ERK pathway. Front Biosci (Landmark Ed) 17:2667\u20132674","journal-title":"Front Biosci (Landmark Ed)"},{"key":"5178_CR9","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1073\/pnas.82.19.6409","volume":"82","author":"KA Thomas","year":"1985","unstructured":"Thomas KA, Rios-Candelore M, Gimenez-Gallego G, DiSalvo J, Bennett C, Rodkey J, Fitzpatrick S (1985) Pure brain-derived acidic Fibroblast Growth Factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1. Proc Natl Acad Sci USA 82:6409\u20136413","journal-title":"Proc Natl Acad Sci USA"},{"key":"5178_CR10","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1288\/00005537-199208000-00016","volume":"102","author":"M Schiff","year":"1992","unstructured":"Schiff M, Gonzalez A, Ong M, Baird A (1992) Juvenile nasopharyngeal angiofibroma contain an angiogenic growth factor: basic FGF. Laryngoscope 102:940\u2013945","journal-title":"Laryngoscope"},{"key":"5178_CR11","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1161\/STROKEAHA.108.534644","volume":"40","author":"P Narasimhan","year":"2009","unstructured":"Narasimhan P (2009) VEGF stimulates the ERK 1\/2 signalling pathway and apoptosis in cerebral endothelial cells after ischemic conditions. Stroke 40:1467\u20131473","journal-title":"Stroke"},{"issue":"2","key":"5178_CR12","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1161\/01.ATV.0000110502.10593.06","volume":"24","author":"MR Abid","year":"2004","unstructured":"Abid MR, Guo S, Minami T, Spokes KC, Ueki K, Skurk C, Walsh K, Aird WC (2004) Vascular endothelial growth factor activates PI3K\/Akt\/forkhead signaling in endothelial cells. Arterioscler Thromb Vasc Biol 24(2):294\u2013300 (Epub 2003 Dec 1)","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"5178_CR13","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1161\/01.RES.0000022200.71892.9F","volume":"90","author":"I Shiojima","year":"2002","unstructured":"Shiojima I, Walsh K (2002) Role of Akt signalling in vascular homeostasis and angiogenesis. Circ Res 90(12):1243\u20131250","journal-title":"Circ Res"},{"key":"5178_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cytogfr.2005.01.004","volume":"16","author":"M Presta","year":"2005","unstructured":"Presta M, Dell\u2019Era P, Mitola S, Moroni E, Ronca R, Rusnati M (2005) Fibroblast growth factor\/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16:159\u2013178","journal-title":"Cytokine Growth Factor Rev"},{"key":"5178_CR15","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/0006-291X(92)92277-5","volume":"189","author":"MS Pepper","year":"1992","unstructured":"Pepper MS, Ferrara N, Orci L, Montesano R (1992) Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189:824\u2013831","journal-title":"Biochem Biophys Res Commun"},{"key":"5178_CR16","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0022-3565(24)29231-4","volume":"299","author":"JC Tille","year":"2001","unstructured":"Tille JC, Wood J, Mandriota SJ, Schnell C, Ferrari S, Mestan J, Zhu Z, Witte L, Pepper MS (2001) Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro. J Pharmacol Exp Ther 299:1073\u20131085","journal-title":"J Pharmacol Exp Ther"},{"key":"5178_CR17","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/S0002-9440(10)64325-8","volume":"162","author":"R Giavazzi","year":"2003","unstructured":"Giavazzi R, Sennino B, Coltrini D, Garofalo A, Dossi R, Ronca R, Tosatti MP, Presta M (2003) Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. Am J Pathol 162:1913\u20131926","journal-title":"Am J Pathol"},{"key":"5178_CR18","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1080\/00313020701444549","volume":"39","author":"YH Shi","year":"2007","unstructured":"Shi YH, Bingle L, Gong LH, Wang YX, Corke KP, Fang WG (2007) Basic FGF augments hypoxia induced HIF-1-alpha expression and VEGF release in T47D breast cancer cells. Pathology 39:396\u2013400","journal-title":"Pathology"},{"issue":"7","key":"5178_CR19","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1083\/jcb.141.7.1659","volume":"141","author":"G Seghezzi","year":"1998","unstructured":"Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P (1998) Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 141(7):1659\u20131673","journal-title":"J Cell Biol"},{"key":"5178_CR20","doi-asserted-by":"publisher","first-page":"843085","DOI":"10.1155\/2012\/843085","volume":"2012","author":"N Okumura","year":"2012","unstructured":"Okumura N, Yoshida H, Kitagishi Y, Murakami M, Nishimura Y, Matsuda S (2012) PI3K\/AKT\/PTEN signaling as a molecular target in leukemia angiogenesis. Adv Hematol 2012:843085. https:\/\/doi.org\/10.1155\/2012\/843085","journal-title":"Adv Hematol"},{"key":"5178_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc969","volume":"3","author":"J Downward","year":"2003","unstructured":"Downward J (2003) Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3:11\u201322","journal-title":"Nat Rev Cancer"},{"key":"5178_CR22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/sj.onc.1206921","volume":"23","author":"KN Meadows","year":"2004","unstructured":"Meadows KN, Bryant P, Vincent PA, Pumiglia KM (2004) Activated ras induces a proangiogenic phenotype in primary endothelial cells. Oncogene 23:192\u2013200. https:\/\/doi.org\/10.1038\/sj.onc.1206921","journal-title":"Oncogene"},{"key":"5178_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1590\/S1516-31801999000300004","volume":"117","author":"CM Coutinho","year":"1999","unstructured":"Coutinho CM, Bassini AS, Gutie\u00b4rrez LG et al (1999) Genetic alterations in Ki-ras and Ha-ras genes in juvenile nasopharyngeal angiofibromas and head and neck cancer. Sao Paulo Med J 117:113\u2013120","journal-title":"Sao Paulo Med J"},{"key":"5178_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/ijc.1599","volume":"97","author":"G Breieri","year":"2002","unstructured":"Breieri G, Blumi S, Peli J, Grooti M, Wild C, Risau W, Richmann E (2002) Transforming growth factor-b and Ras regulate the VEGF\/VRGF receptor system during tumour angiogenesis. Int J Cancer 97:142\u2013148","journal-title":"Int J Cancer"},{"issue":"6 Pt 1","key":"5178_CR25","first-page":"G1345","volume":"276","author":"MK Jones","year":"1999","unstructured":"Jones MK, Itani RM, Wang H, Tomikawa M, Sarfeh IJ, Szabo S, Tarnawski AS (1999) Activation of VEGF and Ras genes in gastric mucosa during angiogenic response to ethanol injury. Am J Physiol 276(6 Pt 1):G1345\u2013G1355","journal-title":"Am J Physiol"},{"issue":"52","key":"5178_CR26","doi-asserted-by":"publisher","first-page":"49289","DOI":"10.1074\/jbc.M108069200","volume":"276","author":"KN Meadows","year":"2001","unstructured":"Meadows KN, Bryant P, Pumiglia K (2001) Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation. J Biol Chem 276(52):49289\u201349298","journal-title":"J Biol Chem"},{"key":"5178_CR27","first-page":"361","volume":"13","author":"S Yamada","year":"2002","unstructured":"Yamada S, Yoshimura A (2002) Computer modeling of Ras-MAPK signal transduction pathway. Genome Inform 13:361\u2013362","journal-title":"Genome Inform"},{"key":"5178_CR28","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1038\/sj.onc.1202680","volume":"18","author":"P Klint","year":"1999","unstructured":"Klint P, Kanda S, Kloog Y, Claesson-Welsh L (1999) Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation. Oncogene 18:3354\u20133364","journal-title":"Oncogene"},{"key":"5178_CR29","doi-asserted-by":"crossref","unstructured":"Yan D, Ellman MB, Muddasani P, Cs-Szabo G, Im HJ (2012) FGF-2 promotes catabolism via FGFR1-Ras-Raf-MEK1\/2-ERK1\/2 axis and PKCd pathway in articular chondrocytes. Poster No. 1718 \u2022 ORS 2012 Annual Meeting","DOI":"10.1002\/jcb.24160"},{"issue":"1","key":"5178_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cell.2012.08.033","volume":"151","author":"Z Nie","year":"2012","unstructured":"Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green DR, Tessarollo L, Casellas R, Zhao K, Levens D (2012) c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151(1):68\u201379. https:\/\/doi.org\/10.1016\/j.cell.2012.08.033 . (PMC 3471363.PMID 23021216)","journal-title":"Cell"},{"key":"5178_CR31","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1073\/pnas.102173199","volume":"99","author":"D Levens","year":"2002","unstructured":"Levens D (2002) Disentangling the MYC web. Proc Natl Acad Sci USA 99:5757\u20135759","journal-title":"Proc Natl Acad Sci USA"},{"key":"5178_CR32","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/00005537-199602000-00016","volume":"106","author":"MA Nagai","year":"1996","unstructured":"Nagai MA, Butugan O, Logullo A, Brentani MM (1996) Expression of growth factors, protooncogenes and p53 in nasopharyngeal angiofibromas. Laryngoscope 106:190\u2013195","journal-title":"Laryngoscope"},{"key":"5178_CR33","first-page":"453","volume":"13","author":"B Schick","year":"2005","unstructured":"Schick B, Veldung B, Wemmert S, Jung V, Montenarh M, Meese E, Urbschat S (2005) p53 and Her-2\/neu in juvenile angiofibromas. Oncol Rep 13:453\u2013457","journal-title":"Oncol Rep"},{"issue":"17","key":"5178_CR34","doi-asserted-by":"publisher","first-page":"7423","DOI":"10.1128\/MCB.25.17.7423-7431.2005","volume":"25","author":"JSL Ho","year":"2005","unstructured":"Ho JSL, Ma W, Mao DYL, Benchimol S (2005) p53-dependent transcriptional repression of c-myc is required for G1 cell cycle arrest. Mol Cell Biol 25(17):7423\u20137431","journal-title":"Mol Cell Biol"},{"key":"5178_CR35","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/0092-8674(94)90534-7","volume":"78","author":"HL Symonds","year":"1994","unstructured":"Symonds HL. Krall L, Remington M, Saenz-Robles S, Lowe T, Jacks, Van Dyke T (1994) p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78:703\u2013711","journal-title":"Cell"},{"key":"5178_CR36","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1128\/MCB.17.2.723","volume":"17","author":"JE Hundley","year":"1997","unstructured":"Hundley JE, Koester SK, Troyer DA, Hilsenbeck SG, Subler MA, Windle JJ (1997) Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53. Mol Cell Biol 17:723\u2013731","journal-title":"Mol Cell Biol"},{"key":"5178_CR37","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1101\/gad.13.20.2658","volume":"13","author":"CM Eischen","year":"1999","unstructured":"Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL (1999) Disruption of the ARFMdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev 13:2658\u20132669","journal-title":"Genes Dev"},{"key":"5178_CR38","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/cdd.2014.15","volume":"21","author":"TJ Phesse","year":"2014","unstructured":"Phesse TJ, Myant KB, Cole AM, Ridgway RA, Pearson H, Muncan V, van den Brink GR, Vousden KH, Sears R, Vassilev LT, Clarke AR, Sansom OJ (2014) Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo. Cell Death Differ 21:956\u2013966. https:\/\/doi.org\/10.1038\/cdd.2014.15","journal-title":"Cell Death Differ"},{"issue":"9","key":"5178_CR39","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1073\/pnas.0808042106","volume":"106","author":"M Sachdeva","year":"2009","unstructured":"Sachdeva M, Zhua S, Wua F, Wua H, Waliab V, Kumarb S, Elbleb R, Watabea K, Moa YY (2009) p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 106(9):3207\u20133212. https:\/\/doi.org\/10.1073\/pnas.0808042106","journal-title":"Proc Natl Acad Sci USA"},{"key":"5178_CR40","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.5858\/2003-127-1480-GFARIJ","volume":"127","author":"PJ Zhang","year":"2003","unstructured":"Zhang PJ, Weber R, Liang H, Pasha TL, LiVolsi VA (2003) Growth factors and receptors in juvenile nasopharyngeal angiofibroma and nasal polyps. Arch Pathol Lab Med 127:1480\u20131484","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"5178_CR41","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1080\/00313020802035857","volume":"40","author":"J Pauli","year":"2008","unstructured":"Pauli J, Gundelach R, Vanelli-Rees A, Rees G, Campbell C, Dubey S, Perry C (2008) Juvenile nasopharyngeal angiofibroma: an immunohistochemical characterisation of the stromal cell. Pathology 40(4):396\u2013400. https:\/\/doi.org\/10.1080\/00313020802035857","journal-title":"Pathology"},{"key":"5178_CR42","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1038\/sj.onc.1202979","volume":"18","author":"NP Koritschoner","year":"1999","unstructured":"Koritschoner NP, Bartunek P, Knespel S, Blendinger G, Zenke M (1999) The Fibroblast growth factor receptor FGFR-4 acts as a ligand dependent modulator of erythroid cell proliferation. Oncogene 18:5904\u20135914","journal-title":"Oncogene"},{"key":"5178_CR43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/jcp.10038","volume":"190","author":"PE Burger","year":"2002","unstructured":"Burger PE, Lukey PT, Coetzee S, Wilson EL (2002) Basic fibroblast growth factor modulates the expression of glycophorin A and c-kit and inhibits erythroid differentiation in K562 Cells. J Cell Physiol 190:83\u201391","journal-title":"J Cell Physiol"},{"key":"5178_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5810908","author":"D Singla","year":"2016","unstructured":"Singla D, Wang J (2016) Fibroblast growth factor-9 Activates c-Kit progenitor cells and enhances angiogenesis in the infarcted diabetic heart. Oxidative Med Cell Longev (Hindawi Publishing Corporation). https:\/\/doi.org\/10.1155\/2016\/5810908 (Article ID 5810908)","journal-title":"Oxidative Med Cell Longev (Hindawi Publishing Corporation)"},{"key":"5178_CR45","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1128\/MCB.21.6.2144-2153.2001","volume":"21","author":"N Bardeesy","year":"2001","unstructured":"Bardeesy N, Bastian BC, Hezel A, Pinkel D, DePinho RA, Chin L (2001) Dual inactivation of RB and p53 pathways in RAS-induced melanomas. Mol Cell Biol 21:2144\u20132153","journal-title":"Mol Cell Biol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00405-018-5178-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-018-5178-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-018-5178-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T22:47:59Z","timestamp":1775256479000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00405-018-5178-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["5178"],"URL":"https:\/\/doi.org\/10.1007\/s00405-018-5178-y","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,1]]},"assertion":[{"value":"15 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declared that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}